These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 16045031

  • 21. Frequency of hepatorenal syndrome among cirrhotics.
    Kumar R, Ahmed R, Rathi SK, Sethar GH.
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):590-3. PubMed ID: 19810292
    [Abstract] [Full Text] [Related]

  • 22. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
    Sharma P, Kumar A, Shrama BC, Sarin SK.
    Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715
    [Abstract] [Full Text] [Related]

  • 23. Platelet-activating factor in human normal tears.
    Okumura N, Kojima K, Hashida M, Koura Y, Fukushima A, Ueno H.
    Curr Eye Res; 2005 Oct; 30(10):891-6. PubMed ID: 16251126
    [Abstract] [Full Text] [Related]

  • 24. Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses.
    Menzies-Gow NJ, Sepulveda MF, Bailey SR, Cunningham FM, Elliott J.
    Am J Vet Res; 2008 Feb; 69(2):199-207. PubMed ID: 18241016
    [Abstract] [Full Text] [Related]

  • 25. Pathogenesis and treatment of hepatorenal syndrome.
    Arroyo V, Fernandez J, Ginès P.
    Semin Liver Dis; 2008 Feb; 28(1):81-95. PubMed ID: 18293279
    [Abstract] [Full Text] [Related]

  • 26. Treatment of hepatorenal syndrome.
    Kiser TH, Maclaren R, Fish DN.
    Pharmacotherapy; 2009 Oct; 29(10):1196-211. PubMed ID: 19792993
    [Abstract] [Full Text] [Related]

  • 27. Effects of platelet-activating factor and platelet-activating factor: acetylhydrolase on in vitro post-thaw boar sperm parameters.
    Bathgate R, Maxwell WM, Evans G.
    Theriogenology; 2007 Mar 01; 67(4):886-92. PubMed ID: 17157372
    [Abstract] [Full Text] [Related]

  • 28. [Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome].
    Saracyn M, Wesołowski P, Nowak Z, Patera J, Kozłowski W, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr 01; 24(142):298-302. PubMed ID: 18634359
    [Abstract] [Full Text] [Related]

  • 29. [Study on the expressions and roles of renal heat shock protein 72 and Toll-like receptor 4 in hepatorenal syndrome in rat].
    Yan CG, Zhu DF, Wang F.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec 01; 19(12):731-4. PubMed ID: 18093430
    [Abstract] [Full Text] [Related]

  • 30. New treatments of hepatorenal syndrome.
    Arroyo V, Terra C, Ginès P.
    Semin Liver Dis; 2006 Aug 01; 26(3):254-64. PubMed ID: 16850375
    [Abstract] [Full Text] [Related]

  • 31. [Hepatorenal syndrome].
    Mijac D, Kezić A, Stojimirović B.
    Srp Arh Celok Lek; 2007 Aug 01; 135(1-2):98-104. PubMed ID: 17503577
    [Abstract] [Full Text] [Related]

  • 32. Seminal platelet-activating factor.
    Roudebush WE.
    Semin Thromb Hemost; 2007 Feb 01; 33(1):69-74. PubMed ID: 17253192
    [Abstract] [Full Text] [Related]

  • 33. Platelet activating factor and its metabolite promote sleep in rabbits.
    Kushikata T, Fang J, Krueger JM.
    Neurosci Lett; 2006 Feb 20; 394(3):233-8. PubMed ID: 16263215
    [Abstract] [Full Text] [Related]

  • 34. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M, Pépin MN, Guevara M, Díaz F, Torre A, Monescillo A, Soriano G, Terra C, Fábrega E, Arroyo V, Rodés J, Ginès P, TAHRS Investigators.
    Gastroenterology; 2008 May 20; 134(5):1352-9. PubMed ID: 18471512
    [Abstract] [Full Text] [Related]

  • 35. Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome.
    Skagen C, Einstein M, Lucey MR, Said A.
    J Clin Gastroenterol; 2009 Aug 20; 43(7):680-5. PubMed ID: 19238094
    [Abstract] [Full Text] [Related]

  • 36. Therapy insight: Management of hepatorenal syndrome.
    Cárdenas A, Ginès P.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun 20; 3(6):338-48. PubMed ID: 16741553
    [Abstract] [Full Text] [Related]

  • 37. The hepatorenal syndrome.
    Munoz SJ.
    Med Clin North Am; 2008 Jul 20; 92(4):813-37, viii-ix. PubMed ID: 18570944
    [Abstract] [Full Text] [Related]

  • 38. Plasma platelet activating factor in nephrotic syndrome.
    Camici M, Sagripanti A.
    Minerva Med; 2001 Oct 20; 92(5):325-7. PubMed ID: 11675576
    [Abstract] [Full Text] [Related]

  • 39. Immediate recovery of renal function after orthotopic liver transplantation in a patient with hepatorenal syndrome requiring hemodialysis for more than 8 months.
    Storm C, Bernhardt WM, Schaeffner E, Neuhaus R, Pascher A, Neuhaus P, Hasper D, Frei U, Kahl A.
    Transplant Proc; 2007 Mar 20; 39(2):544-6. PubMed ID: 17362778
    [Abstract] [Full Text] [Related]

  • 40. Effects of platelet-activating factor, thromboxane A2 and leukotriene D4 on isolated perfused rat liver.
    Cui S, Shibamoto T, Liu W, Takano H, Kurata Y.
    Prostaglandins Other Lipid Mediat; 2006 Jul 20; 80(1-2):35-45. PubMed ID: 16846785
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.